Loading…

Pyran, Inc. closed a $3 million investment from Kowa as part of its Series B round, raising over $5 million total, to build a world-scale commercial plant for bio-based 1,5-pentanediol (PDO) expected to begin operating in 2027.
“Pyran, Inc. continues its trajectory toward building a world-scale commercial plant for 1,5-pentanediol (PDO) after closing its latest round of fundraising, which includes a $3 million investment from Kowa.”renewable-carbon.eu
Summarized from public sources; check the original articles before acting on it.